Q2 2021
Released Aug 12, 2021, after the close
10-Q filed Aug 12, 2021, 43 days after period end · 0001789769-21-000052
Q2 2021 · 10-Q
Revenue$0.00$0.00 −100.0% vs Q2 2020no prior Q1 2021 on file
Net Income-$35.31M-$35.31M N/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.27-$0.27 N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$35,381,000N/M
Operating Cash Flowderived-$32,224,000N/M
Free Cash Flowderived-$40,717,000N/M
What the release said
The release
Same quarter
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $0.00 | $42.00K |
| Net Income | -$35.31M | -$9.20M |
| EPS Diluted | -$0.27 | -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR